Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05974553 · ClinicalTrials.gov registry record · NA

Dialectical Behavior Therapy for Justice-Involved Veterans

A NA study of Psychosocial Functioning and Criminal Behavior, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT05974553: Recruiting NA study of Psychosocial Functioning and Criminal Behavior, sponsored by VA Office of Research and Development.

NCT05974553 is a NA study of Psychosocial Functioning and Criminal Behavior that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 200 participants, above the 143-participant average among 9 other Psychosocial Functioning trials with a reported enrollment target (40% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05974553, a NA study of Psychosocial Functioning and Criminal Behavior, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is a comprehensive, integrative program distinctively designed to address the range of mental health, substance use, case management, and legal needs of Veterans with current or ongoing criminal justice involvement. Data from two prior clinical trials attest to the program's feasibility and acceptability and preliminarily suggest participation in the program may yield meaningful improvements in risk for criminal behavior and resolution of high-priority case management needs. However, continued research is needed to further investigate the program's efficacy. This Phase III clinical trial aims to investigate the superiority of DBT-J over a supportive group therapy treatment in decreasing risk of future criminal behavior and increasing psychosocial functioning. Secondary and exploratory aims will also investigate superiority of DBT-J in improving secondary treatment targets, potential differential efficacy across special-interest Veteran subgroups, and long-term consequences of program participation.

Primary Outcome

semi-structured interview assessment of risk for future criminal justice involvement; score range = 0-43, with higher scores indicating greater risk for future criminal justice involvement

Interventions

  • BEHAVIORAL Dialectical Behavior Therapy for Justice-Involved Veterans
  • BEHAVIORAL Supportive Group Psychotherapy for Justice-Involved Veterans

Study Locations (2)

Colorado

  • Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora

New York

  • James J. Peters VA Medical Center, Bronx, NY - The Bronx

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-01-01
Est. Completion 2027-12-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05974553 shows while recruiting

NCT05974553 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 143-participant average among 9 other Psychosocial Functioning trials with a reported enrollment target (40% higher).

The record links to 3 conditions, with Psychosocial Functioning appearing as the primary indexed condition, and to 2 interventions - of which Dialectical Behavior Therapy for Justice-Involved Veterans is the first listed.

NCT05974553 reports a single indexed study location in Colorado, New York.

Frequently Asked Questions

What is clinical trial NCT05974553 about?

NCT05974553 is a clinical study titled "Dialectical Behavior Therapy for Justice-Involved Veterans". Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is a comprehensive, integrative program distinctively designed to address the range of mental health, substance use, case management, and legal needs of Veterans with current or ongoing criminal justice involvement. Data from two pri...

What is the current status of trial NCT05974553?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-01-01. Estimated completion is 2027-12-31.

What conditions does trial NCT05974553 study?

This clinical trial studies the following conditions: Psychosocial Functioning, Criminal Behavior, Criminal Recidivism.

What interventions are being tested in trial NCT05974553?

The interventions under investigation include: Dialectical Behavior Therapy for Justice-Involved Veterans (BEHAVIORAL), Supportive Group Psychotherapy for Justice-Involved Veterans (BEHAVIORAL).

Who is sponsoring clinical trial NCT05974553?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05974553 being conducted?

This trial has 2 study locations across Colorado, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychosocial Functioning

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05974553's enrollment target sits among peer trials

200 4th of 9 higher than 6 of 9 other Psychosocial Functioning trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychosocial Functioning trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05974553, the US trial registry maintained by the National Library of Medicine. NCT05974553 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.